Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CBFB | Q13951 | 10/20 | 0.38 |
| ▸ | PDE5A | O76074 | 3/20 | 0.35 |
| ▸ | PDE4A | P27815 | 3/20 | 0.35 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.35 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 4/20 | 0.34 |
| ▸ | RAB9A | P51151 | 4/20 | 0.34 |
| ▸ | RUNX1 | Q01196 | 2/20 | 0.34 |
| ▸ | GABRP | O00591 | 1/20 | 0.33 |
| ▸ | GABRD | O14764 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3522525 | 0.84 | CBFB (0.40) | CBFBNPC1RAB9ARUNX1METAP2 | |
| SCHEMBL28338004 | 0.80 | CYP1A2 (0.39) | CYP2D6CYP2C19CYP1A2CYP19A1CYP2C9 | |
| SCHEMBL31392583 | 0.78 | CBFB (0.46) | CBFBNPC1RAB9AMETAP2METAP1 | |
| SCHEMBL9582382 | 0.78 | NPC1 (0.44) | CBFBNPC1RAB9AMETAP2METAP1 | |
| SCHEMBL28347682 | 0.77 | CBFB (0.44) | CBFBNPC1RAB9ARUNX1METAP2 | |
| SCHEMBL28140534 | 0.76 | CBFB (0.43) | CBFBNPC1RAB9ARUNX1METAP2 | |
| SCHEMBL6009235 | 0.76 | NPC1 (0.35) | CBFBPDE4BPDE4DNPC1RAB9A | |
| SCHEMBL28252316 | 0.75 | STAT3 (0.45) | CYP1A2PDE5AGABRPGABRDGABRA1 | |
| SCHEMBL27971649 | 0.74 | STAT3 (0.44) | CYP1A2PDE5AGABRPGABRDGABRA1 | |
| SCHEMBL28169160 | 0.74 | STAT3 (0.42) | PDE5APDE4APDE4BPDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4603096-A1 | METHODS, COMPOSITIONS, AND KITS FOR TREATING AND/OR PREVENTING A SIDE EFFECT ASSOCIATED WITH RADIATION AND/OR CHEMOTHERAPY EXPOSURE | Biomimetix JV LLC (US) | 2025-08-20 | — | — | EP | disclosed |
| EP-3606614-B1 | METHODS, COMPOSITIONS, AND KITS FOR TREATING AND/OR PREVENTING A SIDE EFFECT ASSOCIATED WITH RADIATION AND/OR CHEMOTHERAPY EXPOSURE | BIOMIMETIX JV LLC (US) | 2025-05-21 | — | — | EP | disclosed |
| US-20250041314-A1 | METHODS, COMPOSITIONS, AND KITS FOR TREATING AND/OR PREVENTING A SIDE EFFECT ASSOCIATED WITH RADIATION AND/OR CHEMOTHERAPY EXPOSURE | BIOMIMETIX JV LLC (US) | 2025-02-06 | — | — | US | disclosed |
| US-12171769-B2 | Methods, compositions, and kits for treating and/or preventing a side effect associated with radiation and/or chemotherapy exposure | BIOMIMETIX JV, LLC (US) | 2024-12-24 | — | — | US | disclosed |
| US-20220193090-A1 | METHODS, COMPOSITIONS, AND KITS FOR TREATING AND/OR PREVENTING A SIDE EFFECT ASSOCIATED WITH RADIATION AND/OR CHEMOTHERAPY EXPOSURE | BIOMIMETIX JV, LLC | 2022-06-23 | — | — | US | disclosed |
| US-11285162-B2 | Methods, compositions, and kits for treating and/or preventing a side effect associated with radiation and/or chemotherapy exposure | BIOMIMETIX JV, LLC (US) | 2022-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220193090-A1 | METHODS, COMPOSITIONS, AND KITS FOR TREATING AND/OR PREVENTING A SIDE EFFECT ASSOCIATED WITH RADIATION AND/OR CHEMOTHERAPY EXPOSURE | MRE11, XRCC5, RAD51 | CYP2D6 3328/4885CYP2C19 3687/4885CYP1A2 2598/4885 |
| US-20250041314-A1 | METHODS, COMPOSITIONS, AND KITS FOR TREATING AND/OR PREVENTING A SIDE EFFECT ASSOCIATED WITH RADIATION AND/OR CHEMOTHERAPY EXPOSURE | MRE11, XRCC5, RAD51 | CYP2D6 3328/4885CYP2C19 3687/4885CYP1A2 2598/4885 |
| US-11285162-B2 | Methods, compositions, and kits for treating and/or preventing a side effect associated with radiation and/or chemotherapy exposure | MRE11, XRCC5, RAD51 | CYP2D6 3328/4885CYP2C19 3687/4885CYP1A2 2598/4885 |
| US-12171769-B2 | Methods, compositions, and kits for treating and/or preventing a side effect associated with radiation and/or chemotherapy exposure | MRE11, XRCC5, RAD51 | CYP2D6 3328/4885CYP2C19 3687/4885CYP1A2 2598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.